Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma

Cancer

Volumn 116, Issue 10, 2010, Pages 2429-2436

  Ardoino, Ilaria ^a   Miceli, Rosalba ^a   Berselli, Mattia ^a   Mariani, Luigi ^a   Biganzoli, Elia ^a,b   Fiore, Marco ^a   Collini, Paola ^a   Stacchiotti, Silvia ^a   Casali, Paolo Giovanni ^a   Gronchi, Alessandro ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Nomogram; Prognosis; Retroperitoneal sarcoma; Sarcoma; Survival

Indexed keywords

ADULT; AGE; ARTICLE; CANCER GRADING; CANCER PATIENT; EXTERNAL VALIDITY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTERNAL VALIDITY; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NOMOGRAM; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROPERITONEAL SARCOMA; RISK ASSESSMENT; SOFT TISSUE SARCOMA; TUMOR VOLUME; ADOLESCENT; AGED; CANCER STAGING; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROPERITONEAL TUMOR; SARCOMA; STATISTICAL MODEL; TREATMENT OUTCOME; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS; RETROPERITONEAL NEOPLASMS; SARCOMA; TREATMENT OUTCOME;

EID: 77952557154     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25057     Document Type: Article

References (32)

1. Brennan M, Singer S, Maki RG, O'Sullivan B. Soft tissue sarcoma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:1741-1794.
2. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355-365. (Pubitemid 30191698)
3. Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448-2455.
4. Lahat G, Tuvin D, Wei C, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol. 2008;15:2739-2748.
5. Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC Staging System. Ann Surg. 2009;250:970-976.
6. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359-368. (Pubitemid 32664443)
7. Catton CN, O'Sullivan B, Kotwall C, Cummings B, Hao Y, Fornasier V. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1994;29: 1005-1010.
8. Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007; 67:158-163.
9. Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995;221:185-195.
10. Van Doorn RC, Gallee MP, Hart AA, et al. Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer. 1994;73:637-642.
11. Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg. 2004;239:244-250. (Pubitemid 38176359)
12. Van Dalen T, Plooij JM, van Coevorden F, et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol. 2007;33:234-238.
13. Anaya DA, Lahat G, Wang X, et al. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. Ann Surg Oncol. 2009;16:667-675.
14. Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24-30.
15. Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31-37.
16. Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364-1370.
17. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791-796.
18. Eilber FC, Brennan MF, Eilber FR, Dry SM, Singer S, Kattan MW. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2005;101:2270-2275. (Pubitemid 39458683)
19. Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a 3-grade system. Cancer. 2005;101:402-408. (Pubitemid 40129301)
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
21. Greenacre M. Correspondence analysis in medical research. Stat Methods Med Res. 1992;1:97-117.
22. Boracchi P, Biganzoli EM, Marubini E. Joint modelling of cause specific hazard functions with cubic splines: an application to a large case series of breast cancer patients. Comp Stat Data Anal. 2003;42:243-262. (Pubitemid 36261175)
23. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187-220.
24. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathologic grading system. Int J Cancer. 1984;33:37-42.
25. Harrell FE Jr. Regression modelling strategies with applications to linear models, logistic regression, and survival analysis. New York, NY: Springer; 2001.
26. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
27. Antolini L, Boracchi P, Biganzoli EM. A time-dependent discrimination index for survival data. Stat Med. 2005;24: 3927-3944.
28. Coradini D, Daidone MG, Boracchi P, et al. Time-dependent relevance of steroid receptors in breast cancer. J Clin Oncol. 2000;18:2702-2709.
29. Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381-391.
30. Canter RJ, Qin LX, Maki RG, Brennan MF, Ladanyi M, Singer S. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res. 2008;14:8191-8197.
31. Anaya DA, Lahat G, Wang X, et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010;21:397-402.
32. Mussi C, Collini P, Miceli R, et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer. 2008;113:1657-1665.